Sliding scale insulin use in a national cohort study of nursing home residents with type 2 diabetes.

ABSTRACT:

Background

Guidelines discourage sliding scale insulin (SSI) use after the first week of a nursing home (NH) admission. We sought to determine the prevalence of SSI and identify factors associated with stopping SSI or transitioning to another short-acting insulin regimen.

Methods

In an observational study from October 1, 2013, to June 30, 2017 of non-hospice Veterans Affairs NH residents with type 2 diabetes and an NH admission over 1 week, we compared the weekly prevalence of SSI versus two other short-acting insulin regimens - fixed dose insulin (FDI) or correction dose insulin (CDI, defined as variable SSI given alongside fixed doses of insulin) - from week 2 to week 12 of admission. Among those on SSI in week 2, we examined factors associated with stopping SSI or transit

SUBMITTER: Lam K 

PROVIDER: S-EPMC9283241 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature